MedTrace Logo

Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport

NCT06307418 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2025-05-29

No results posted yet for this study

Summary

The aim of this randomized controlled trial is to investigate the effects of internet-based support (Carer eSupport) on preparedness for caregiving in informal caregivers of patients with head and neck cancer. The main question\[s\] it aims to answer are:

* What are the effects of internet-based support on informal caregivers preparedness for caregiving?
* What are the effects of internet-based support on informal caregivers burden and wellbeing?

Informal caregivers who are randomized to Carer eSupport will have access to Carer eSupport for 18 weeks and they will be asked to complete questionnaires (outcome measures) at:

* baseline (before randomization)
* 18 weeks (post-intervention) and at
* 3 months after the intervention is completed (long term follow-up).

Informal caregivers in the intervention group will be compared to informal caregivers who receive standard care support regarding preparedness for caregiving, caregiver burden and wellbeing.

Conditions

Interventions

OTHER

Carer eSupport

Internet-based support

Sponsors & Collaborators

  • The Swedish Research Council

    collaborator OTHER_GOV

  • Swedish Cancer Society

    collaborator OTHER

  • Umeå University

    collaborator OTHER

  • Region Örebro County

    collaborator OTHER

  • Sahlgrenska University Hospital

    collaborator OTHER

  • University Hospital, Umeå

    collaborator OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Ylva Tiblom Ehrsson, Assoc prof · Uppsala University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-20
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06307418 on ClinicalTrials.gov